Trinity Biotech’s Trinovium Inks AI Data Center Cooling Deal with Red Team Investments
Event summary
- Trinovium, a subsidiary of Trinity Biotech, signed a contract with Red Team Investments (RTI) to supply advanced liquid cooling solutions for AI data center infrastructure.
- The deal includes a commercial pilot program for Trinovium’s cooling fluids and analytical systems in a U.S. data center environment.
- RTI will provide operational performance data and feedback to support product validation and broader commercialization.
- The data center liquid cooling market is projected to grow from $4 billion in 2026 to $27 billion by 2033.
The big picture
The deal underscores the increasing demand for advanced liquid cooling solutions as AI workloads drive higher power densities in data centers. Trinity Biotech’s pivot into this sector leverages its expertise in fluid manufacturing and analytical technologies, positioning it to capitalize on a market projected to grow significantly over the next decade. The collaboration with RTI provides a critical real-world validation opportunity for Trinovium’s technology.
What we're watching
- Market Expansion
- How Trinovium’s success in this pilot will affect its broader commercialization efforts in the rapidly growing data center liquid cooling market.
- Technical Validation
- Whether Trinovium’s cooling fluids and analytical systems can meet the operational demands of high-density AI data centers.
- Strategic Partnerships
- The pace at which Trinovium can secure additional partnerships with data center operators to scale its technology.
Related topics